1. Home
  2. GV vs GNPX Comparison

GV vs GNPX Comparison

Compare GV & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Visionary Education Technology Holdings Group Inc.

GV

Visionary Education Technology Holdings Group Inc.

HOLD

Current Price

$1.21

Market Cap

4.8M

Sector

Real Estate

ML Signal

HOLD

Logo Genprex Inc.

GNPX

Genprex Inc.

HOLD

Current Price

$1.92

Market Cap

4.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GV
GNPX
Founded
2013
2009
Country
Canada
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
4.2M
IPO Year
2022
2018

Fundamental Metrics

Financial Performance
Metric
GV
GNPX
Price
$1.21
$1.92
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
48.3K
194.3K
Earning Date
08-14-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,773,905.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$1.71
52 Week High
$9.60
$55.00

Technical Indicators

Market Signals
Indicator
GV
GNPX
Relative Strength Index (RSI) 39.35 36.17
Support Level $1.12 $1.71
Resistance Level $1.25 $1.88
Average True Range (ATR) 0.08 0.16
MACD -0.01 0.01
Stochastic Oscillator 44.46 23.62

Price Performance

Historical Comparison
GV
GNPX

About GV Visionary Education Technology Holdings Group Inc.

Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: